Evidence map›Paper›PMID 41388022›Full record

ArticleNature communications2025

Engineering the auxin-inducible degron system for tunable in vivo control of organismal physiology.

Jeremy Vicencio, Daisuke Chihara, Matthias Eder, Lucia Sedlackova, Julie Ahringer, Nicholas Stroustrup

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Autophagy: A Double-Edged Sword in the Aging ofInternational journal of molecular sciences · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jeremy VicencioCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID http://orcid.org/0000-0002-7291-3365
Daisuke ChiharaCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Matthias EderCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Lucia SedlackovaCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID http://orcid.org/0000-0003-4482-088X
Julie AhringerThe Gurdon Institute and Department of Genetics, University of Cambridge, Cambridge, UK.
Nicholas StroustrupCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain. nicholas.stroustrup@crg.eu.ORCID http://orcid.org/0000-0001-9530-7301

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 852201Ministerio de Economía, Industria y Competitividad, Gobierno de España (Ministerio de Economía, Industria y Competitividad) BFU2017-88615-PNIH HHS P40 OD010440RCUK | Medical Research Council (MRC) MR/S021620/1Wellcome TrustWellcome Trust 217170
6 · The paper itself

Abstract

The auxin-inducible degron (AID) system is designed for the rapid and near-complete degradation of a specific target protein in vivo. However, to understand the dynamics of complex physiological networks, researchers often need methods that produce graded, quantitative changes in degradation rates for multiple proteins simultaneously. Here, we develop the AID system for in vivo, quantitative control over the abundance of multiple proteins simultaneously. First, by measuring and modeling the on- and off-target activities of different AID system variants in Caenorhabditis elegans, we characterize a variant of the E3 ubiquitin ligase subunit TIR1, which provides improved degradation activity compared to the original AID and AID2 systems. Then, we develop a TIR1 expression construct that enables simultaneous pan-somatic and germline protein degradation. Finally, we expand the AID toolkit to allow independent, simultaneous degradation of two distinct tissue-specific proteins. Together, these technologies enable new in vivo approaches for studying quantitative cellular biology and organismal dynamics.

Indexed as

Caenorhabditis elegansIndoleacetic AcidsProteolysisAnimalsArabidopsis ProteinsCaenorhabditis elegans ProteinsDegronsF-Box ProteinsReceptors, Cell SurfaceUbiquitin-Protein LigasesArabidopsis ProteinsCaenorhabditis elegans ProteinsF-Box ProteinsIndoleacetic AcidsReceptors, Cell SurfaceTIR1 protein, ArabidopsisUbiquitin-Protein Ligases

Identifiers

PMID41388022
PMCPMC12700905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.